Oncternal Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ONCT for the last quarter is 569.00 k USD, and it's 91.58% higher compared to the previous quarter. The net income of Q1 24 is -8.39 M USD.